Guidelines

NICE guideline on Thyroid cancer: assessment and management: NG230 December 2022

2022 European Thyroid Association Guideline for the management of pediatric Graves’ disease

The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy

NHS England: Liothyronine - advice for prescribers August 2023

Consensus Guidance on Routine Practice for Differentiated Thyroid Cancer in Scotland May 2020

2018 European Thyroid Association Guideline on the Management of Graves' Hyperthyroidism

Joint Statement from the Society for Endocrinology and the British Thyroid Association regarding "Association of Radioactive Iodine Treatment with Cancer Mortality in Patients with Hyperthyroidism" December 2019
This statement was published in response to an article published in JAMA Internal Medicine Association of Radioactive Iodine Treatment with Cancer Mortality in Patients with Hyperthyroidism July 2019 

NICE Guideline on Thyroid Disease: assessment and management 2019

Updated RMOC Guidance - Prescribing of Liothyronine 2019

ATA Guideline for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum 2017

ATA Guidelines for Managing Thyroid Nodules and Thyroid Cancer in Children 2015

BTA Guidelines for the Management of Thyroid Cancer 2014

2014 European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism in Pregnancy and in Children

Statements

Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement June 2023

Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association December 2022

Liothyronine (T3): Answering patients' questions 2016 
This frequently asked questions (FAQ) sheet has been produced for patients who are on treatment with Liothyronine (T3) and are concerned that they may be required to switch to thyroxine.  

BTA Statement on the management of primary hypothyroidism 2015 
This statement has been produced to help patients make informed decisions about their treatment. There is a wealth of advice published on the internet but often it is confusing and misleading and the BTF believes that hypothyroid patients have the right to know what this information is based on and how reliable it is. This updated statement sets out the references to the research it is based on, and also a guide to the strength of the recommendations made and the quality of the evidence used.

BTF FAQ for the management of primary hypothyroidism 2015
The BTF has produced a set of Questions and Answers which accompany the BTA Statement on the Management of Primary Hypothyroidism 2015

Screening for thyroid disorders in the elderly 2011 
A joint statement from the British Thyroid Association and the BTF

Reports

Getting It Right First Time (GIRFT) report on endocrinology

Further information on liothyronine 

Please help us help others

With your support we can help people to live better with thyroid disease. Your donations also fund vital research to improve treatments.

Please consider making a donation or becoming a member

Donate to BTF

Become a BTF member